April 26, 2021- April 26, 2021/ 11:00 am - 3:00 pm
Medical innovations driven by the biopharmaceutical industry have played a fundamental role in helping people live longer, healthier lives. As the global population’s health needs become increasingly complex, it is ever more essential that we research and develop life-saving medicines and vaccines to meet these challenges. Intellectual Property (IP) has been central to great scientific advances and for ensuring that patients have access to this innovation. IP helps foster long term investment to benefit patients – today and tomorrow.
CEO, UCB & Chair of the Biopharmaceutical CEO Roundtable (BCR)
CEO, Alzheimer’s Disease International
Sune Stampe Sørensen
Director General, Danish Patent and Trademark Office
Director General, IFPMA